Condition
Thrombotic Microangiopathies clinical trials and research
As of November 12, 2026, Find a Trial lists 9 Thrombotic Microangiopathies clinical trials that are recruiting, at sites in 10 countries (most in China (3), Netherlands (2), United States (2)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 10Countries
Newest Thrombotic Microangiopathies clinical trials
All recruiting trials (9)
-
Role of Interferon and Complement in Second-ary Thrombotic Microangiopathy
This study tests whether interferon levels relate to the development of TA-TMA in people who have had a transplant or related conditions.
-
Long-term outcomes for people with immune TTP in the French national TMA cohort
This project uses past medical records to see long-term health outcomes and complications in people in France who had immune thrombotic thrombocytopenic purpura (iTTP).
-
Observational study of blood clotting and bleeding disorders in Chinese patients
This study looks at blood clotting and bleeding problems in Chinese patients to see how common they are and what factors might affect them.
-
Immunosuppression and caplacizumab with plasma infusion instead of plasma exchange for immune TTP
This study tests whether adults with immune-mediated TTP can be treated safely and effectively with immunosuppression and caplacizumab plus plasma infusion without daily plasma exchange.
-
Identifying blood markers for early diagnosis of transplant-related complications
This study is trying to find blood markers that can help doctors spot early signs of a serious complication called TA-TMA in patients who have had a stem cell transplant.
-
Evaluating narsoplimab for treating TMA in children after stem cell transplants
This study is testing a new treatment called narsoplimab to see if it can help children who are at high risk for blood vessel problems after getting stem cell transplants.
-
Creating a database for patients with thrombotic microangiopathies
This study is creating a detailed database to collect important information about patients with thrombotic microangiopathies to help improve understanding and treatment of the condition.
-
Examining complement-related thrombotic microangiopathy that injures the blood vessel lining
This project will test whether a new endothelial cell-based blood test can detect complement overactivation as the cause of thrombotic microangiopathy in adults with acute kidney injury and TMA.
-
Long-term observation of lung injury in children after stem cell transplants
This study looks at children who have had stem cell transplants to see how often they develop lung problems and how these issues affect their health over time.
Related topics
Quick answers
How many Thrombotic Microangiopathies clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in China (3 trials), Netherlands (2 trials), United States (2 trials), France (2 trials), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.